000 01661 a2200445 4500
005 20250515153017.0
264 0 _c20090512
008 200905s 0 0 eng d
022 _a1651-226X
024 7 _a10.1080/02841860802609574
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWolter, Pascal
245 0 0 _aFlare-up: an often unreported phenomenon nevertheless familiar to oncologists prescribing tyrosine kinase inhibitors.
_h[electronic resource]
260 _bActa oncologica (Stockholm, Sweden)
_c2009
300 _a621-4 p.
_bdigital
500 _aPublication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
650 0 4 _aBone Neoplasms
_xcomplications
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aDisease Progression
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIndoles
_xadministration & dosage
650 0 4 _aKidney Neoplasms
_xpathology
650 0 4 _aLiver Neoplasms
_xdrug therapy
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aNephrectomy
650 0 4 _aPain
_xetiology
650 0 4 _aProtein Kinase Inhibitors
_xadministration & dosage
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aPyrroles
_xadministration & dosage
650 0 4 _aSunitinib
650 0 4 _aTomography, X-Ray Computed
700 1 _aBeuselinck, Benoit
700 1 _aPans, Steven
700 1 _aSchöffski, Patrick
773 0 _tActa oncologica (Stockholm, Sweden)
_gvol. 48
_gno. 4
_gp. 621-4
856 4 0 _uhttps://doi.org/10.1080/02841860802609574
_zAvailable from publisher's website
999 _c18557969
_d18557969